Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Exchange Rate Effect (2010 - 2025)

Grifols' (GIFLF) quarterly Exchange Rate Effect came in at -$109.4 million in Q4 2025, down 565.44% on a YoY basis from $23.5 million in Q4 2024, and down 565.44% quarter-over-quarter from $23.5 million in Q4 2024.

Analysis

Grifols (GIFLF) Exchange Rate Effect (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Exchange Rate Effect for 14 consecutive years, with -$109.4 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 565.44% year-over-year to -$109.4 million; the trailing twelve-month figure through Dec 2025 stood at -$86.9 million (down 208.78% YoY), and the FY2025 full-year result was -$106.2 million, down 551.75% from the prior year.
  • Exchange Rate Effect retreated to -$109.4 million in Q4 2025 per GIFLF's latest filing, from $23.5 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $23.5 million in Q4 2024 and bottomed at -$109.4 million in Q4 2025.
  • Historically, Exchange Rate Effect has averaged -$34.0 million across 3 years, with a median of -$16.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect jumped 245.67% in 2024, then slumped 565.44% in 2025.
  • Over 3 years, Exchange Rate Effect stood at -$16.1 million in 2023, then surged by 245.67% to $23.5 million in 2024, then plunged by 565.44% to -$109.4 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$109.4 million, $23.5 million, and -$16.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -300,000.00
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -2.45 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 315,000.00
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -109.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -109.42 Mn
Dec 31, 2024 23.51 Mn
Dec 31, 2023 -16.14 Mn
Mar 31, 2020 15.12 Mn
Dec 31, 2019 57.43 Mn
Mar 31, 2019 22.27 Mn
Dec 31, 2018 33.48 Mn
Jun 30, 2018 54.75 Mn
Mar 31, 2018 -27.72 Mn
Dec 31, 2017 -102.07 Mn
Jun 30, 2017 -79.63 Mn
Mar 31, 2017 11.32 Mn
Dec 31, 2016 66.14 Mn
Sep 30, 2016 -51.23 Mn
Jun 30, 2016 86.73 Mn
Dec 31, 2015 901,008.40
Sep 30, 2015 -3.90 Mn
Jun 30, 2015 124.23 Mn
Mar 31, 2015 143.83 Mn
Dec 31, 2014 1.51 Mn